Recommendations on use of systemic treatments for immune-mediated dermatologic disorders in patients with confirmed COVID-19 infection: A rapid review
With the rapid outbreak of the coronavirus disease 2019 (COVID-19) pandemic, considerable concerns about the safety of systemic treatments of immune-mediated dermatologic disorders has been raised by dermatologists and their patients. We aimed to perform a rapid review of latest American and Europea...
Main Authors: | Chia-Ling Yu, Yu-Ting Lin, Ching-Chi Chi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Dermatologica Sinica |
Subjects: | |
Online Access: | http://www.dermsinica.org/article.asp?issn=1027-8117;year=2022;volume=40;issue=2;spage=67;epage=70;aulast=Yu |
Similar Items
-
A Summary of 2018 and What Lies Ahead for Dermatology and Therapy in 2019
by: Alan Menter, et al.
Published: (2019-02-01) -
Exploring the use of probiotics in dermatology – a literature review
by: Monika Sroczyńska, et al.
Published: (2023-01-01) -
Bidirectional relationships between psychological health and dermatological conditions in children
by: Mitchell AE
Published: (2018-07-01) -
Establishment of a Nationwide Patient Database for Clinical Trial Recruitment in Dermatology: Concept and Patient Characteristics
by: Dorra Bouazzi, et al.
Published: (2021-05-01) -
Letter in reply: Linear IgA bullous dermatosis treated with dupilumab in a pediatric patient with glucose-6-phosphate dehydrogenase deficiency
by: Sonal Muzumdar, MD, et al.
Published: (2024-02-01)